PROactive
Physical Activity as a Crucial Patient Reported Outcome in COPD

- Durada
- 01/09/2009 - 31/05/2016
- Coordinador
- Judith Garcia Aymerich
- Finançadors
- Innovative Medicines Initiative (IMI) Partner
- Pàgina web
- https://www.imi.europa.eu/content/pro-active
Physical activity (PA) is essential in maintaining optimal health in chronic diseases, including COPD. More physically active COPD patients have less hospital admissions and better survival. Validated physical activity monitors have become available in recent years, but it is unknown how patients experience physical activity and how physical activity is best assessed comprehensively in patients with COPD (and chronic disease in general).
The aim of PROactive was to develop and validate two Patient Reported Outcome (PRO) instruments for the measure of physical activity in COPD patients, one for the measure on a daily basis, and the second for its use during clinical trial visits (7-days recall).
For the development of the first draft of the PROs we combined data from systematic reviews of the literature, interviews with patients, and experts’ opinion. The PROs were used in an observational longitudinal study to reduce their items and be initially validated with respect to reliability and construct validity. The resulting pre-final PROs versions were included in large multicentre clinical trials for final validation mainly with respect to validity and responsiveness to change.
The PROactive project delivered two hybrid tools combining a short PRO questionnaire and two activity monitor variables and covering two domains: difficulty with physical activities, and amount of physical activity. These tools allow the assessment of physical activity in COPD patients in a daily basis (D-PACC) or during a clinical visit (C-PACC).
Total funding
433,568 €
Our Team
Coordinator
-
Judith Garcia Cap del programa de Malalties No Transmissibles i Medi Ambient
Team
-
Xavier Basagaña Associate Research Professor
Altres projectes
Veure projectes passatsMCC-Spain
Estudi multi-cas control poblacional, incloent tumors d'alta incidència a Espanya
ALEC (Aging Lungs in European Cohorts)
Ageing Lungs in European Cohorts
QUALI-VERD
OMEGA-NET
Network on the Coordination and Harmonisation of European Occupational Cohorts
Global Assessment of Trihalomethanes in Drinking Water
POLLAR
Impact Of Pollution on Asthma and Rhinitis
EPHOR
Exposome Project for Health and Occupational Research
CORSAIR
Severe respiratory failure in COVID-19: clinical, biological and imaging risk factors
VEIS
Valorización de l'Arxiu Europeu del Genoma-Fenoma (EGA) per a la Indústria i la Societat
Mobilise-D
Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
COVICAT
Cohorte Covid-19 en Cataluña
EARLY-ADAPT
Signs of Early Adaptation to Climate Change
AiguaBCN
Exposure to emerging contaminants in drinking water in Barcelona potentially liked to chronic diseases and wellbeing
Fotovoz
Las Voces de los Afectados por la Nefropatía Mesoamericana
Metabolomic Analysis as a Window into the Etiology of Mesoamerican Nephropathy
CALMA
Co-created educational programme for dyspnea-bearing patients and their caregivers
Cancer-Watch
Risk of colorectal and breast cancer with widespread drinking water chemical contaminants
CONTENT
Cohort de COVID-19 a Espanya: dinàmica social, salut mental i desigualtats
EXPANSE
EXposome Powered tools for healthy living in urbAN SEttings
COVAIR-CAT
Air Pollution in Relation to COVID-19 Morbidity and Mortality: A Large Population-Based Cohort Study in Catalonia
Alimentación S2: por una dieta saludable y sostenible
Estudi sobre l'exposició a nano i microplàstics a través de l'aigua de consum de Barcelona
És millor consumir l'aigua d'aixeta si volem reduir l'exposició a nano/microplàtics?
Laboratori Ciutadà de Salut Urbana
Characterizing Oral Exposure to Nanoplastics and Microplastics
Characterization of Oral NMP Exposure
iGenCO
In-Depth Genomics and Cross-Omics Analysis for Undiagnosed Rare Diseases on a User-Friendly Collaborative Platform